Correction: Value of combining biological age with assessment of individual frailty to optimize mana...
Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
About this item
Full title
Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
BMC cancer, 2024-07, Vol.24 (1), p.806-1, Article 806
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Alternative Titles
Full title
Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_09a245be07c04bcab9240273c9ae9df6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_09a245be07c04bcab9240273c9ae9df6
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-024-12592-0
